Advanced CKD/Dialysis : Safe use is possible with close supervision and personalized plans
Lower baseline insulin doses, shorter duration of diabetes, and lower HbA1c levels were associated with greater success in transitioning from insulin to a GLP-1 agonist [34, 35]
Nevertheless, the authors warn against too much euphoria, as there are still some challenges ahead
By mimicking the hormone GLP-1which prompts insulin release and helps regulate blood sugarSemaglutide lowers blood glucose levels, curbs hunger, and supports weight loss when paired with a diet and exercise plan
In an initial pilot study, we demonstrated the need for more comprehensive validation [2]
Everything is designed around a deep understanding of members real lives and goals, so support feels personal, connected, and consistent wherever someone meets Weight Watchers. Availability The new experience will be available in Canada in early January 2026